Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (4): 400-406.doi: 10.12092/j.issn.1009-2501.2023.04.006

Previous Articles     Next Articles

Correlation between progesterone receptor G1978T polymorphism and endometrial cancer

ZHOU Jing1,3, ZHOU Chen1, LIAO Ke1, QIU Ailin1, DONG Weilei2, GUO Zifen1   

  1. 1Institute of Pharmacy and Pharmacology, School of Pharmaceutical Science, Hengyang Medical College, University of South China, Hengyang 421001, Hunan, China; 2Department of Obstetrics and Gynecology, the First Affiliated Hospital of University of South China, Hengyang 421001, Hunan, China; 3Department of Pharmacy, the First Affiliated Hospital of Shaoyang University, Shaoyang 422001, Hunan, China 
  • Received:2023-03-17 Revised:2023-04-25 Online:2023-04-26 Published:2023-05-17

Abstract:

AIM: To explore the relationship between progesterone receptor (PGR) gene G1978T polymorphism and endometrial carcinoma. METHODS: After searching PubMed, EMBASE, Wan-fang and CNKI databases for literatures on PGR G1978T genotyping of endometrial cancer patients, the da- ta were extracted and odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using STATA15. The whole blood samples of endometrial carcinoma cases (EC group) and normal women (control group) were collected. Allelic-specific primers matching G1978T wild type G allele and mutant type T allele were designed with 3'terminal phos-phorothioate modification, and the two-directional primer extension was performed using Exo+polymerase to genotype PGR gene G1978T polymorphism and Sanger sequencing was used to  verify the genotype. RESULTS: PGR gene G1978T mutation was marginally associated with endometrial carcinoma risk (ORper allele =1.10,95%CI=0.98-1.24, P=0.072). At the same time, only 1 normal blood samples were found with PGR gene G1978T mutation, and the differences in genotypes and allele frequency between the case group and the control group were not statistically significant(P>0.05).CONCLUSION: The G1978T polymorphism of the PGR gene maybe not be associated with the risk of endometrial carcinoma.

Key words: endometrial carcinoma, progesterone receptor, G1978T polymorphism

CLC Number: